logo

$5 And Under

Share

Optical Cable Corp. (OCC) reported second quarter EPS of $0.18 Monday morning, compared to the loss of $0.04 in the previous year. Optical Cable has gapped open sharply higher this morning and is now up 0.80 at $3.80 on the highest volume of the year. The stock has leaped to a new high for the year.

The Committee on Foreign Investment in the United States announced Saturday that it has approved China Oceanwide Holdings Group acquisition of Genworth Financial Inc. (GNW). Genworth Financial has gapped open sharply higher Monday morning and is now up 1 point at $4.81 on above average volume. The...

EDAP TMS SA (EDAP) announced after the bell Thursday that it has received FDA 510(k) clearance for its Focal One device. The device is used for the ablation of prostate tissue. EDAP has gapped open sharply higher Friday morning and is now up 1.62 at $3.83 on the highest volume of the year. The stock...

Axovant Sciences Ltd. (AXON) announced early Wednesday morning that it has licensed the exclusive worldwide rights to develop and commercialize AXO-Lenti-PD, a treatment for Parkinson's disease, from Oxford BioMedica. Axovant Sciences has gapped open sharply higher this morning and is now up 1.72...

AMERI Holdings Inc. (AMRH) announced Tuesday morning that it has entered into a partnership with Bayestree Intelligence Inc. AMERI Holdings gapped up sharply Tuesday and has continued to rise in early trade. Shares are now up 1.61 at $2.42. The stock has jumped to over a 3-month high.

J. Jill Group (JILL) reported first quarter adjusted EPS of $0.29 Thursday morning, up from $0.24 in the prior year period. The consensus estimate was for EPS of $0.20. J. Jill Group gapped open sharply higher this morning and is now up 1.18 at $7.38. The stock has jumped to over a 2-month high.

Catalyst Pharmaceutical Partners (CPRX) announced after the close Tuesday that the FDA has accepted its New Drug Application for Firdapse for a Priority Review. The drug is a treatment for Lambert-Eaton myasthenic syndrome. Catalyst Pharmaceutical Partners has been rising since the open of trade Wednesday...

TransEnterix Inc. (TRXC) announced Tuesday morning that it has received FDA 510(k) clearance for expanded indications of its Senhance Surgical System. TransEnterix gapped open sharply higher this morning and is now up 0.50 at $3.63. The stock has climbed to a 7-month high.

Follow RTT